Brevan Howard Capital Management »

Contineum Therapeutics shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $551k 42k 13.06
2025-12-31 $222k 19k 11.43

More positions owned by Brevan Howard Capital Management

Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr Iboxx Inv Cp Etf (LQD)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Pdd Holdings Sponsored Ads (PDD)
Ishares Tr China Lg-cap Etf (FXI)
Spdr Gold Tr Gold Shs (GLD)
Select Sector Spdr Tr State Street Fin (XLF)
Agnc Invt Corp Com reit (AGNC)
Ishares Msci Brazil Etf (EWZ)
Meta Platforms Cl A (META)
Palantir Technologies Cl A (PLTR)

View all positions for Brevan Howard Capital Management

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Henderson Group
Johnson & Johnson
Franklin Resources
Balyasny Asset Management
Millennium Management
Baker Bros. Advisors
RA Capital Management
Vanguard Group
Perceptive Advisors
Vanguard Capital Management
FMR
Ikarian Capital
Sectoral Asset Management
Dr. Jeffrey R. Jay, M.D.

View all funds holding Contineum Therapeutics